Personalized Active Immunotherapy (Vaccine Therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Personalized Active Immunotherapy (Vaccine Therapy), covering 2008-03-18 to 2008-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma [Phase 2]